Since only a few early-stage ovarian carcinomas can be diagnosed, it is difficult to predict the disease progression using standard clinical or pathological prognostic factors, such as grade, stage, or expressions of CA125/MUC16. This evidence concerns the gene MUC16 and ovarian carcinoma.